CLENE INC

Clene Inc. insider buying signals boost confidence in its ALS drug CNM‑Au8; CEO’s option exercise coincides with NDA filing and promising clinical data.

Insider buying surges at Clene Inc., with top execs buying shares to back its neuro‑therapeutic platform. Gain insight into the bullish signal and what it means for investors.